COMPARISON OF VARIANT GENETICS IN GSTP1 GENE IN LOCAL BREAST CANCER PATIENTS AND HEALTHY INDIVIDUALS

Main Article Content

Naila Rafiq
Sadia Falak
Irum Javid
Naheed Sajjad
Farah Naz Channa
Farrukh Bashir
Tanzila Sahar
Shamaila Rafiq
Fiza Munir

Keywords

Breast Cancer, GSTP1, Gentic Polymorphism, Alw26I, Ethnic Variation

Abstract

The Glutathione S-transferases P-1 (GSTP1) was Phase II metabolic enzyme caused detoxification of xenobiotics. Polymorphism in this enzyme was seen in different ethnic groups and might be related to difference in metabolism. Some carcinogens and mutagens are considered directly or indirectly involved in developing distinct sort of carcinoma. Single nucleotide polymorphism might lead to varying metabolic activity of resulting enzymes and could be tested for relation with disease occurrence. GSTP1 had two polymorphic sites that had conversions usually in the exon 5, A→G transition by nucleotide 313 near to codon 105 (Ile105↔Val105). A Polymerase Chain Reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analysis was conducted by using Alw261. All the digests were electrophoresed on a gel with optimized to 3.5% ultrapure agarose. It was found that the mutant genotype G/G was significantly high in breast cancer patients compared to normal individuls

Abstract 51 | pdf Downloads 17

References

1. Attia, D. H., Eissa, M., Samy, L. A., & Khattab, R. A. (2021). Influence of glutathione S transferase A1 gene polymorphism (-69C> T, rs3957356) on intravenous cyclophosphamide efficacy and side effects: a case-control study in Egyptian patients with lupus nephritis. Clinical rheumatology, 40, 753-762.
2. Youssef, M. M., Elsaid, A. M., El-Saeed, R. A., Mukhlif, R. T., Megahed, H., Al-Alawy, A. I., &Elshazli, R. M. (2021). Association of GSTP1 p. Ile105Val (rs1695, c. 313A> G) variant with the risk of breast carcinoma among Egyptian women. Biochemical Genetics, 59(6), 1487-1505.
3. Cui, J., Li, G., Yin, J., Li, L., Tan, Y., Wei, H., ... & Yi, L. (2020). GSTP1 and cancer: Expression, methylation, polymorphisms and signaling. International journal of oncology, 56(4), 867-878.
4. Kagita Sailaja, D., Rao, D. N., Rao, D. R., & Vishnupriya, S. (2010). Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia. Asian Pacific Journal of Cancer Prevention, 11(2), 461-64.
5. Albarakati, N., Khayyat, D., Dallol, A., Al-Maghrabi, J., &Nedjadi, T. (2019). The prognostic impact of GSTM1/GSTP1 genetic variants in bladder cancer. BMC cancer, 19, 1-11.
6. Pongtheerat, T., Treetrisool, M., &Purisa, W. (2009). Glutathione s-transferase polymorphisms in breast cancers of Thai patients. Asian Pac J Cancer Prev, 10(1), 127-32.
7. Sengupta, D., Banerjee, S., Mukhopadhyay, P., Guha, U., Ganguly, K., Bhattacharjee, S., & Sengupta, M. (2020). A meta-analysis and in silico analysis of polymorphic variants conferring breast cancer risk in the Indian subcontinent. Future Oncology, 16(27), 2121-2142.
8. Pongtheerat, T., Pakdeethai, S., Purisa, W., Chariyalertsak, S., &Petmitr, S. (2011). Promoter methylation and genetic polymorphism of glutathione S-transferase P1 gene (GSTP1) in Thai breast-cancer patients. Asian Pac J Cancer Prev, 12(10), 2731-4.
9. Saxena, A., Dhillon, V. S., Shahid, M., Khalil, H. S., Rani, M., PRASAD DAS, T. R. I. N. A. T. H., ... & Husain, S. A. (2012). GSTP1 methylation and polymorphism increase the risk of breast cancer and the effects of diet and lifestyle in breast cancer patients. Experimental and therapeutic medicine, 4(6), 1097-1103.
10. Sergentanis, T. N., & Economopoulos, K. P. (2010). GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis. Breast cancer research and treatment, 121, 195-202.
11. Ge, J., Tian, A. X., Wang, Q. S., Kong, P. Z., Yu, Y., Li, X. Q., ... & Feng, Y. M. (2013). The GSTP1 105Val allele increases breast cancer risk and aggressiveness but enhances response to cyclophosphamide chemotherapy in North China. PloS one, 8(6), e67589.
12. Ma, J., Zhu, S. L., Liu, Y., Huang, X. Y., & Su, D. K. (2017). GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer. Oncotarget, 8(42), 72939.

Most read articles by the same author(s)